SCHEMBL874851

SCHEMBL874851

O=C(O)c1cc(I)c[nH]1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27757069 0.79
SCHEMBL20792669 0.79
SCHEMBL4550730 0.79
SCHEMBL370477 0.74 BAZ2B (0.54)
SCHEMBL2513855 0.74 ALDH1A1 (0.51)
SCHEMBL3579931 0.74 BRD4 (0.46)
SCHEMBL162194 0.73
SCHEMBL162193 0.73
SCHEMBL70598 0.73 SMN1; SMN2 (0.62)
SCHEMBL21712949 0.73 BAZ2B (0.53)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111148734-B Pyrrole-2-formamide compound and preparation method and application thereof 中国医学科学院药物研究所 2023-01-06 CN disclosed
CN-111148734-A Pyrrole-2-formamide compound and preparation method and application thereof 中国医学科学院药物研究所 2020-05-12 CN disclosed
WO-2019042267-A1 PYRROLE-2-FORMAMIDE COMPOUND, AND PREPARATION METHOD THEREFOR AND APPLICATIONS THEREOF 中国医学科学院药物研究所 2019-03-07 WO disclosed
EP-2632469-A2 TRICYCLIC MGLUR5 RECEPTOR MODULATORS Merck Sharp & Dohme Corp. (US) 2013-09-04 EP disclosed
US-20130210804-A1 TRICYCLIC MGLUR5 RECEPTOR MODULATORS MERCK SHARP & DOHME CORP. 2013-08-15 US disclosed
US-20130210804-A1 TRICYCLIC MGLUR5 RECEPTOR MODULATORS MERCK SHARP & DOHME CORP. 2013-08-15 US disclosed
US-20130210804-A1 TRICYCLIC MGLUR5 RECEPTOR MODULATORS MERCK SHARP & DOHME CORP. 2013-08-15 US disclosed
WO-2012172093-A1 DIHYDROINDOLIZINE DERIVATE AS METABOTROPIC GLUTAMATE RECEPTOR MODULATORS MERZ PHARMA GMBH & CO. KGAA (DE) 2012-12-20 WO disclosed
WO-2012061019-A2 TRICYCLIC MGLUR5 RECEPTOR MODULATORS MERCK SHARP & DOHME CORP. (US) 2012-05-10 WO disclosed
WO-2012061019-A2 TRICYCLIC MGLUR5 RECEPTOR MODULATORS MERCK SHARP & DOHME CORP. (US) 2012-05-10 WO disclosed
WO-2012038904-A1 NICOTINAMIDE DERIVATIVES, PREPARATION THEREOF AND THERAPEUTIC USE THEREOF SANOFI (FR) 2012-03-29 WO disclosed
EP-1090008-A4 SYNTHESES OF A VARIETY OF LAMELLARIN COMPOUNDS AND ANALOGUES UNIV AUSTRALIAN (AU) 2003-01-02 EP disclosed
US-6469171-B1 NON-TOXIC MODULATORS OF THE MULTIDRUG RESISTANT PHENOTYPE THE AUSTRALIAN NATIONAL UNIVERSITY (AU) 2002-10-22 US disclosed
EP-1090008-A1 SYNTHESES OF A VARIETY OF LAMELLARIN COMPOUNDS AND ANALOGUES THE AUSTRALIAN NATIONAL UNIVERSITY (AU) 2001-04-11 EP disclosed
WO-1999067250-A1 SYNTHESES OF A VARIETY OF LAMELLARIN COMPOUNDS AND ANALOGUES THE AUSTRALIAN NATIONAL UNIVERSITY (AU) 1999-12-29 WO disclosed
EP-0658553-B1 Polycyclic aromatic compounds, pharmaceutical and cosmetic compositions containing them and uses thereof CIRD GALDERMA (FR) 1998-11-04 EP disclosed
EP-0661258-B1 Biaromatic propynyl compounds, pharmaceutical compositions and cosmetics containing them and their uses CIRD GALDERMA (FR) 1998-04-08 EP disclosed
EP-0661258-A1 Biaromatic propynyl compounds, pharmaceutical compositions and cosmetics containing them and their uses CENTRE INTERNATIONAL DE RECHERCHES DERMATOLOGIQUES GALDERMA, ( CIRD GALDERMA) (FR) 1995-07-05 EP disclosed
EP-0658553-A1 Polycyclic aromatic compounds, pharmaceutical compositions containing them and uses thereof CENTRE INTERNATIONAL DE RECHERCHES DERMATOLOGIQUES GALDERMA, ( CIRD GALDERMA) (FR) 1995-06-21 EP disclosed